Skip to main content
. 2020 Feb 29;14(2):21–44. doi: 10.3941/jrcr.v14i2.3712

Table 1.

Summary table for complex solid and cystic breast cancers

Etiology
  • Typically arises when a solid mass gradually fills and dilates a lactiferous duct.

  • Occasionally arises when a solid malignant mass secretes mucin/fluid or undergoes necrosis.

Incidence
  • Complex solid and cystic masses found in approximately 5% of breast ultrasound examinations.

  • Malignant potential of complex solid and cystic masses: between 23 and 31%.

Gender Ratio
  • Females > Males

Median Age Predilection
  • Variable based on diagnosis:

    • ○ IDC: 62

    • ○ DCIS: 74.5

    • ○ Mucinous: 62.3

    • ○ IPC: 69.5

Risk Factors
  • Female gender

  • Family history of breast cancer

  • BRCA1/BRCA2 mutations

  • Early age of menarche

  • Late age of menopause

  • Nulliparity

  • Obesity

  • Caucasian race

Treatment
  • Surgical excision (mastectomy or breast conservation therapy)

  • Adjuvant radiation, chemotherapy, and/or hormonal therapy

Prognosis
  • Variable based on the receptor status of the tumor with triple negative carcinoma conferring the worst prognosis and ER+/PR+/HER2− tumors conferring the best prognosis.

Imaging Findings
  • Ultrasound: a cyst with thick walls (>0.5mm), thick septa (>0.5mm), an intra-cystic mass, or a cyst demonstrating >50% solid components.